Main features of DNA-based immunization vectors

Detalhes bibliográficos
Autor(a) principal: Azevedo,V.
Data de Publicação: 1999
Outros Autores: Levitus,G., Miyoshi,A., Cândido,A.L., Goes,A.M., Oliveira,S.C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200002
Resumo: DNA-based immunization has initiated a new era of vaccine research. One of the main goals of gene vaccine development is the control of the levels of expression in vivo for efficient immunization. Modifying the vector to modulate expression or immunogenicity is of critical importance for the improvement of DNA vaccines. The most frequently used vectors for genetic immunization are plasmids. In this article, we review some of the main elements relevant to their design such as strong promoter/enhancer region, introns, genes encoding antigens of interest from the pathogen (how to choose and modify them), polyadenylation termination sequence, origin of replication for plasmid production in Escherichia coli, antibiotic resistance gene as selectable marker, convenient cloning sites, and the presence of immunostimulatory sequences (ISS) that can be added to the plasmid to enhance adjuvanticity and to activate the immune system. In this review, the specific modifications that can increase overall expression as well as the potential of DNA-based vaccination are also discussed.
id ABDC-1_5dcca6d12693caff02ea2ee0530f7c4d
oai_identifier_str oai:scielo:S0100-879X1999000200002
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Main features of DNA-based immunization vectorsgenetic immunizationDNA plasmidenhancer/promoter regionimmunostimulatory sequences (ISS)antigensimmune responseDNA-based immunization has initiated a new era of vaccine research. One of the main goals of gene vaccine development is the control of the levels of expression in vivo for efficient immunization. Modifying the vector to modulate expression or immunogenicity is of critical importance for the improvement of DNA vaccines. The most frequently used vectors for genetic immunization are plasmids. In this article, we review some of the main elements relevant to their design such as strong promoter/enhancer region, introns, genes encoding antigens of interest from the pathogen (how to choose and modify them), polyadenylation termination sequence, origin of replication for plasmid production in Escherichia coli, antibiotic resistance gene as selectable marker, convenient cloning sites, and the presence of immunostimulatory sequences (ISS) that can be added to the plasmid to enhance adjuvanticity and to activate the immune system. In this review, the specific modifications that can increase overall expression as well as the potential of DNA-based vaccination are also discussed.Associação Brasileira de Divulgação Científica1999-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200002Brazilian Journal of Medical and Biological Research v.32 n.2 1999reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X1999000200002info:eu-repo/semantics/openAccessAzevedo,V.Levitus,G.Miyoshi,A.Cândido,A.L.Goes,A.M.Oliveira,S.C.eng1999-02-04T00:00:00Zoai:scielo:S0100-879X1999000200002Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:1999-02-04T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Main features of DNA-based immunization vectors
title Main features of DNA-based immunization vectors
spellingShingle Main features of DNA-based immunization vectors
Azevedo,V.
genetic immunization
DNA plasmid
enhancer/promoter region
immunostimulatory sequences (ISS)
antigens
immune response
title_short Main features of DNA-based immunization vectors
title_full Main features of DNA-based immunization vectors
title_fullStr Main features of DNA-based immunization vectors
title_full_unstemmed Main features of DNA-based immunization vectors
title_sort Main features of DNA-based immunization vectors
author Azevedo,V.
author_facet Azevedo,V.
Levitus,G.
Miyoshi,A.
Cândido,A.L.
Goes,A.M.
Oliveira,S.C.
author_role author
author2 Levitus,G.
Miyoshi,A.
Cândido,A.L.
Goes,A.M.
Oliveira,S.C.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Azevedo,V.
Levitus,G.
Miyoshi,A.
Cândido,A.L.
Goes,A.M.
Oliveira,S.C.
dc.subject.por.fl_str_mv genetic immunization
DNA plasmid
enhancer/promoter region
immunostimulatory sequences (ISS)
antigens
immune response
topic genetic immunization
DNA plasmid
enhancer/promoter region
immunostimulatory sequences (ISS)
antigens
immune response
description DNA-based immunization has initiated a new era of vaccine research. One of the main goals of gene vaccine development is the control of the levels of expression in vivo for efficient immunization. Modifying the vector to modulate expression or immunogenicity is of critical importance for the improvement of DNA vaccines. The most frequently used vectors for genetic immunization are plasmids. In this article, we review some of the main elements relevant to their design such as strong promoter/enhancer region, introns, genes encoding antigens of interest from the pathogen (how to choose and modify them), polyadenylation termination sequence, origin of replication for plasmid production in Escherichia coli, antibiotic resistance gene as selectable marker, convenient cloning sites, and the presence of immunostimulatory sequences (ISS) that can be added to the plasmid to enhance adjuvanticity and to activate the immune system. In this review, the specific modifications that can increase overall expression as well as the potential of DNA-based vaccination are also discussed.
publishDate 1999
dc.date.none.fl_str_mv 1999-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200002
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1999000200002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-879X1999000200002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.32 n.2 1999
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302929655824384